← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

ACON logoAclarion, Inc.(ACON)Earnings, Financials & Key Ratios

ACON•NASDAQ
$3.28
$3M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryLife Sciences and Precision Medicine Software
AboutAclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.Show more
  • Revenue$75.73B+165624079.9%
  • EBITDA-$7052.39B-132565854.1%
  • Net Income-$7233.63B-103441978.0%
  • EPS (Diluted)-13.61+99.8%
  • Gross Margin9.02%+104.9%
  • EBITDA Margin-9312.55%+20.0%
  • Operating Margin-9312.55%+22.8%
  • Net Margin-9551.87%+37.5%
  • ROE-112.72%+98.0%
  • ROIC-1291.13%
Technical→

ACON Key Insights

Aclarion, Inc. (ACON) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 1631.5%

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Shares diluted 100.0% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ACON Price & Volume

Aclarion, Inc. (ACON) stock price & volume — 10-year historical chart

Loading chart...

ACON Growth Metrics

Aclarion, Inc. (ACON) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years1631.54%
3 Years10680.48%
TTM99999900%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-99999900%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM99.79%

Return on Capital

10 Years-1391.46%
5 Years-1391.46%
3 Years-1771.99%
Last Year-109.89%

ACON Peer Comparison

Aclarion, Inc. (ACON) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
XTNT logoXTNTXtant Medical Holdings, Inc.Direct Competitor80.8M0.58-4.8128.44%1.32%3.77%0.82
GKOS logoGKOSGlaukos CorporationDirect Competitor7.92B135.27-41.2432.33%-34.34%-26.46%0.21
MDXG logoMDXGMiMedx Group, Inc.Product Competitor543.76M3.6611.4419.99%7.88%12.86%0.09
ATEC logoATECAlphatec Holdings, Inc.Product Competitor1.06B6.99-7.2824.95%-21.07%-141.88%17.21
NVCR logoNVCRNovoCure LimitedProduct Competitor1.88B16.50-13.528.28%-25.66%-50.82%0.85
OFIX logoOFIXOrthofix Medical Inc.Product Competitor489.36M12.19-5.352.85%-7.27%-13.44%0.51
ISRG logoISRGIntuitive Surgical, Inc.Supply Chain160.44B451.7357.4020.51%28.15%16.89%0.02
MDT logoMDTMedtronic plcSupply Chain99.48B77.6021.503.62%13%9.45%0.59

Compare ACON vs Peers

Aclarion, Inc. (ACON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs XTNT

Most directly comparable listed peer for ACON.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare ACON against a more recognizable public peer.

Peer Set

Compare Top 5

vs XTNT, GKOS, MDXG, ATEC

ACON Income Statement

Aclarion, Inc. (ACON) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue26.9K48.65K60.29K60.44K75.4K45.72K75.73B
Revenue Growth %-80.88%23.93%0.25%24.75%-39.36%99999900%
Cost of Goods Sold63.18K66.25K69.17K65.3K75.73K129.77K68.9B
COGS % of Revenue234.9%136.16%114.73%108.03%100.43%283.81%90.98%
Gross Profit
-36.28K▲ 0%
-17.59K▲ 51.5%
-8.88K▲ 49.5%
-4.85K▲ 45.4%
-324▲ 93.3%
-84.04K▼ 25839.2%
6.83B▲ 8124512.5%
Gross Margin %-134.9%-36.16%-14.73%-8.03%-0.43%-183.81%9.02%
Gross Profit Growth %-51.51%49.51%45.36%93.33%-25839.2%8124512.5%
Operating Expenses3.98M4.46M2.94M5.56M4.88M5.43M7.06T
OpEx % of Revenue14786.11%9166.87%4883.16%9193.16%6466.05%11873.42%9321.56%
Selling, General & Admin2.24M1.41M2.16M4.49M4M4.59M6.03T
SG&A % of Revenue8329.58%2893.48%3576.44%7426.25%5307.84%10028.32%7956.46%
Research & Development1.74M1.05M787.85K1.07M873.34K888.77K1.03T
R&D % of Revenue6456.53%2162.56%1306.72%1766.91%1158.21%1943.76%1365.1%
Other Operating Expenses02M000-45.11K0
Operating Income
-4.01M▲ 0%
-4.48M▼ 11.6%
-2.95M▲ 34.0%
-5.56M▼ 88.3%
-4.88M▲ 12.3%
-5.51M▼ 13.1%
-7.05T▼ 127921690.6%
Operating Margin %-14921.01%-9203.03%-4897.89%-9201.19%-6466.48%-12057.23%-9312.55%
Operating Income Growth %--11.57%34.05%-88.33%12.33%-13.07%-99999900%
EBITDA-3.84M-4.28M-2.77M-5.42M-4.71M-5.32M-7.05T
EBITDA Margin %-14258.45%-8799.59%-4588.75%-8963.58%-6250.74%-11634.83%-9312.55%
EBITDA Growth %--11.63%35.38%-95.83%13.01%-12.87%-99999900%
D&A (Non-Cash Add-back)178.21K196.28K186.39K143.62K162.67K193.14K227.41K
EBIT-4.01M-4.48M-4.47M-5.56M-4.3M-6.46M-7.05M
Net Interest Income-5K-156.04K-476.48K-1.51M-608.12K-535.15K411.06K
Interest Income01502.51K172318411.06K
Interest Expense5K156.06K476.48K1.51M608.29K535.47K0
Other Income/Expense-5.96K-157.79K-2M-1.51M-35.39K-1.48M-181.24B
Pretax Income
-4.02M▲ 0%
-4.64M▼ 15.3%
-4.95M▼ 6.8%
-7.07M▼ 42.8%
-4.91M▲ 30.5%
-6.99M▼ 42.4%
-7.23T▼ 103441978.0%
Pretax Margin %-14943.15%-9527.35%-8210.53%-11694.45%-6513.41%-15293.78%-9551.87%
Income Tax0000000
Effective Tax Rate %0%0%0%0%0%0%0%
Net Income
-4.02M▲ 0%
-4.64M▼ 15.3%
-4.95M▼ 6.8%
-7.07M▼ 42.8%
-4.91M▲ 30.5%
-6.99M▼ 42.4%
-7.23T▼ 103441978.0%
Net Margin %-14943.15%-9527.35%-8210.53%-11694.45%-6513.41%-15293.78%-9551.87%
Net Income Growth %--15.33%-6.8%-42.79%30.52%-42.38%-99999900%
Net Income (Continuing)-4.02M-4.64M-4.95M-7.07M-4.91M-6.99M-7.23M
Discontinued Operations0000000
Minority Interest0000000
EPS (Diluted)
-97680.00▲ 0%
-110583.00▼ 13.2%
-120035.00▼ 8.5%
-177396.00▼ 47.8%
-79782.00▲ 55.0%
-7480.22▲ 90.6%
-13.61▲ 99.8%
EPS Growth %--13.21%-8.55%-47.79%55.03%90.62%99.82%
EPS (Basic)-97680.00-110583.00-120035.00-177396.00-79782.00-7480.22-13.61
Diluted Shares Outstanding5050504262943532.04K
Basic Shares Outstanding5050504262943532.04K
Dividend Payout Ratio-------

ACON Balance Sheet

Aclarion, Inc. (ACON) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets218.51K97.13K732.2K1.7M1.29M824.28K12.4T
Cash & Short-Term Investments128.16K14.98K432.53K1.47M1.02M453.66K12.02T
Cash Only128.16K14.98K432.53K1.47M1.02M453.66K12.02T
Short-Term Investments0000000
Accounts Receivable14.7K22.5K6.28K18.65K13.42K18.33K29.68K
Days Sales Outstanding199.42168.8238.02112.6464.98146.290
Inventory0000000
Days Inventory Outstanding-------
Other Current Assets0020K59.56K152.22K133.9K380.91B
Total Non-Current Assets1.21M1.19M1.16M1.21M1.17M1.3M1.28T
Property, Plant & Equipment48.51K25.62K12.64K3.35K1.78K5.5K24.17B
Fixed Asset Turnover0.55x1.90x4.77x18.06x42.31x8.31x3.13x
Goodwill0000000
Intangible Assets1.16M1.17M1.14M1.21M1.17M1.29M1.25T
Long-Term Investments0000000
Other Non-Current Assets0000000
Total Assets
1.43M▲ 0%
1.29M▼ 9.7%
1.89M▲ 46.3%
2.91M▲ 54.3%
2.46M▼ 15.6%
2.12M▼ 13.7%
13.67T▲ 643866792.3%
Asset Turnover0.02x0.04x0.03x0.02x0.03x0.02x0.01x
Asset Growth %--9.69%46.27%54.26%-15.61%-13.67%99999900%
Total Current Liabilities3.13M8.38M7.62M688.67K3.19M1.15M837.29B
Accounts Payable501.03K859.53K1.06M457.56K760.53K531.6K332.96K
Days Payables Outstanding2.89K4.74K5.59K2.56K3.67K1.5K0
Short-Term Debt515.55K2.38M2M01.13M00
Deferred Revenue (Current)0000000
Other Current Liabilities2.02M2M0165.95K768.87K543.12K837.29B
Current Ratio0.07x0.01x0.10x2.47x0.40x0.71x14.81x
Quick Ratio0.07x0.01x0.10x2.47x0.40x0.71x14.81x
Cash Conversion Cycle-------
Total Non-Current Liabilities00000011.83M
Long-Term Debt0000000
Capital Lease Obligations0000000
Deferred Tax Liabilities00000011.83M
Other Non-Current Liabilities0000000
Total Liabilities3.13M8.38M7.62M688.67K3.19M1.15M837.29B
Total Debt515.55K2.38M2M01.13M00
Net Debt387.39K2.36M1.57M-1.47M104.66K-453.66K-12.02T
Debt / Equity-------
Debt / EBITDA-------
Net Debt / EBITDA-------
Interest Coverage-803.46x-28.69x-6.20x-3.69x-8.02x-10.30x-
Total Equity
-1.7M▲ 0%
-7.08M▼ 316.2%
-5.73M▲ 19.1%
2.23M▲ 138.9%
-728K▼ 132.7%
970.06K▲ 233.3%
12.84T▲ 1323130087.2%
Equity Growth %--316.21%19.12%138.85%-132.7%233.25%99999900%
Book Value per Share-34300.81-142762.87-115468.6652761.77-11825.831028.87999999.00
Total Shareholders' Equity-1.7M-7.08M-5.73M2.23M-728K970.06K12.84T
Common Stock686895809M
Retained Earnings-20.44M-25.93M-31.89M-39.37M-44.28M-51.26M-58.5T
Treasury Stock0000000
Accumulated OCI0000000
Minority Interest0000000

ACON Cash Flow Statement

Aclarion, Inc. (ACON) cash flow — operating, investing & free cash flow history

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-4.17M-1.79M-2.35M-4.95M-3.65M-5.27M-7.16T
Operating CF Margin %-15508.17%-3687.01%-3897.61%-8187.93%-4836.54%-11529.19%-9460.19%
Operating CF Growth %-57%-31%-110.61%26.31%-44.55%-99999900%
Net Income-4.02M-4.64M-4.95M-7.07M-4.91M-6.99M-7.23T
Depreciation & Amortization178.21K196.28K189.37K143.62K162.67K193.14K227.41B
Stock-Based Compensation28.04K26.13K177.49K1.29M456K287.45K105.37B
Deferred Taxes0000000
Other Non-Cash Items02.08M1.56M1.3M22.88K1.8M-263.35B
Working Capital Changes-358.23K539.9K676.29K-616.1K622.87K-564.24K-357.9K
Change in Receivables-14.7K-7.81K16.22K-12.29K-1.49K7.27K-11.35K
Change in Inventory0000000
Change in Payables-249.96K342.23K199.6K-603.1K220.63K-156.4K-198.64K
Cash from Investing-267.21K-179.03K-152K-207.87K-119.52K-321.94K-203.9B
Capital Expenditures-22.36K-4.74K-152K-208.87K-119.52K-321.94K-203.9K
CapEx % of Revenue83.12%9.74%252.11%345.56%158.51%704.09%0%
Acquisitions0000000
Investments-------
Other Investing-244.86K-174.28K01K00-203.9B
Cash from Financing2.95M1.86M2.94M6.19M3.31M5.03M18.95T
Debt Issued (Net)515.55K1.86M2.94M-2M2.25M-300.97K0
Equity Issued (Net)1000K001000K1000K1000K1000K
Dividends Paid000000-5.42B
Share Repurchases000000-1.21M
Other Financing000-365.06K-398.22K-1.25M18.95T
Net Change in Cash
-1.49M▲ 0%
-113.18K▲ 92.4%
437.55K▲ 486.6%
1.03M▲ 135.5%
-451.74K▼ 143.8%
-567.41K▼ 25.6%
11.58T▲ 2040353426.0%
Free Cash Flow
-4.44M▲ 0%
-1.97M▲ 55.6%
-2.35M▼ 19.1%
-5.16M▼ 119.5%
-3.77M▲ 27.0%
-5.59M▼ 48.5%
-7.16T▼ 128079726.3%
FCF Margin %-16501.65%-4054.98%-3897.61%-8533.49%-4995.05%-12233.28%-9460.19%
FCF Growth %-55.55%-19.12%-119.49%26.98%-48.51%-99999900%
FCF per Share-89452.45-39760.38-47360.88-122259.39-61183.95-5932.66-999999.00
FCF Conversion (FCF/Net Income)1.04x0.39x0.47x0.70x0.74x0.75x0.99x
Interest Paid000010.71K13.07K0
Taxes Paid0000000

ACON Key Ratios

Aclarion, Inc. (ACON) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025
Return on Equity (ROE)----317.55%-655.74%-5777.8%-112.72%
Return on Invested Capital (ROIC)-----5634.28%--1291.13%
Gross Margin-134.9%-36.16%-14.73%-8.03%-0.43%-183.81%9.02%
Net Margin-14943.15%-9527.35%-8210.53%-11694.45%-6513.41%-15293.78%-9551.87%
Interest Coverage-803.46x-28.69x-6.20x-3.69x-8.02x-10.30x-
FCF Conversion1.04x0.39x0.47x0.70x0.74x0.75x0.99x
Revenue Growth-80.88%23.93%0.25%24.75%-39.36%99999900%

ACON Frequently Asked Questions

Aclarion, Inc. (ACON) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Aclarion, Inc. (ACON) reported $75.73B in revenue for fiscal year 2025. This represents a 281555464% increase from $0.0M in 2019.

Aclarion, Inc. (ACON) grew revenue by 99999900.0% over the past year. This is strong growth.

Aclarion, Inc. (ACON) reported a net loss of $7.23T for fiscal year 2025.

Dividend & Returns

Yes, Aclarion, Inc. (ACON) pays a dividend with a yield of 100.00%. This makes it attractive for income-focused investors.

Aclarion, Inc. (ACON) has a return on equity (ROE) of -112.7%. Negative ROE indicates the company is unprofitable.

Aclarion, Inc. (ACON) had negative free cash flow of $7.16T in fiscal year 2025, likely due to heavy capital investments.

Explore More ACON

Aclarion, Inc. (ACON) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.